Are patients with systemic lupus erythematosus at increased risk for COVID-19?
- PMID: 32451344
- DOI: 10.1136/annrheumdis-2020-217787
Are patients with systemic lupus erythematosus at increased risk for COVID-19?
Keywords: antirheumatic agents; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.Ann Rheum Dis. 2021 Feb;80(2):e26. doi: 10.1136/annrheumdis-2020-217859. Epub 2020 May 25. Ann Rheum Dis. 2021. PMID: 32451345 No abstract available.
Comment on
-
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24. Ann Rheum Dis. 2020. PMID: 32332072 No abstract available.